vs
CSG SYSTEMS INTERNATIONAL INC（CSGS）とLantheus Holdings, Inc.（LNTH）の財務データ比較。上の社名をクリックして会社を切り替えられます
Lantheus Holdings, Inc.の直近四半期売上が大きい（$406.8M vs $323.1M、CSG SYSTEMS INTERNATIONAL INCの約1.3倍）。Lantheus Holdings, Inc.の純利益率が高く（13.3% vs 2.2%、差は11.1%）。Lantheus Holdings, Inc.の前年同期比売上増加率が高い（4.0% vs 2.0%）。Lantheus Holdings, Inc.の直近四半期フリーキャッシュフローが多い（$81.4M vs $55.8M）。過去8四半期でLantheus Holdings, Inc.の売上複合成長率が高い（4.9% vs 4.6%）
中国南玻集団股フン有限公司は中国最大級の建築用ガラスメーカーで、浮きガラス、建築用ガラス、ディスプレイ用ガラス、自動車用ガラス、コーティングガラス、鏡、カラーフィルターガラス、太陽光発電用ガラス、省エネガラスなど多種多様なガラス製品の製造・販売を手がけています。
ランティウス・ホールディングスはグローバルな医療企業で、革新的な診断用造影剤や関連ソリューションの開発・製造・販売を事業の核としています。製品は腫瘍学、循環器学、泌尿器学などの分野に対応し、北米を中心に世界の主要市場で事業を展開しています。
CSGS vs LNTH — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $323.1M | $406.8M |
| 純利益 | $7.0M | $54.1M |
| 粗利率 | 50.0% | 59.2% |
| 営業利益率 | 9.0% | 19.0% |
| 純利益率 | 2.2% | 13.3% |
| 売上前年比 | 2.0% | 4.0% |
| 純利益前年比 | -79.7% | 558.8% |
| EPS（希薄化後） | $0.24 | $0.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $323.1M | $406.8M | ||
| Q3 25 | $303.6M | $384.0M | ||
| Q2 25 | $297.1M | $378.0M | ||
| Q1 25 | $299.5M | $372.8M | ||
| Q4 24 | $316.7M | $391.1M | ||
| Q3 24 | $295.1M | $378.7M | ||
| Q2 24 | $290.3M | $394.1M | ||
| Q1 24 | $295.1M | $370.0M |
| Q4 25 | $7.0M | $54.1M | ||
| Q3 25 | $20.5M | $27.8M | ||
| Q2 25 | $12.3M | $78.8M | ||
| Q1 25 | $16.1M | $72.9M | ||
| Q4 24 | $34.5M | $-11.8M | ||
| Q3 24 | $19.1M | $131.1M | ||
| Q2 24 | $13.8M | $62.1M | ||
| Q1 24 | $19.5M | $131.1M |
| Q4 25 | 50.0% | 59.2% | ||
| Q3 25 | 48.1% | 57.9% | ||
| Q2 25 | 49.5% | 63.8% | ||
| Q1 25 | 48.4% | 63.8% | ||
| Q4 24 | 51.3% | 63.5% | ||
| Q3 24 | 49.4% | 63.9% | ||
| Q2 24 | 47.3% | 64.9% | ||
| Q1 24 | 46.5% | 65.4% |
| Q4 25 | 9.0% | 19.0% | ||
| Q3 25 | 10.0% | 11.4% | ||
| Q2 25 | 10.0% | 23.3% | ||
| Q1 25 | 9.8% | 27.4% | ||
| Q4 24 | 13.4% | 29.1% | ||
| Q3 24 | 10.8% | 35.3% | ||
| Q2 24 | 8.8% | 26.1% | ||
| Q1 24 | 10.8% | 28.8% |
| Q4 25 | 2.2% | 13.3% | ||
| Q3 25 | 6.7% | 7.2% | ||
| Q2 25 | 4.1% | 20.8% | ||
| Q1 25 | 5.4% | 19.6% | ||
| Q4 24 | 10.9% | -3.0% | ||
| Q3 24 | 6.5% | 34.6% | ||
| Q2 24 | 4.8% | 15.8% | ||
| Q1 24 | 6.6% | 35.4% |
| Q4 25 | $0.24 | $0.86 | ||
| Q3 25 | $0.73 | $0.41 | ||
| Q2 25 | $0.44 | $1.12 | ||
| Q1 25 | $0.57 | $1.02 | ||
| Q4 24 | $1.20 | $-0.18 | ||
| Q3 24 | $0.67 | $1.79 | ||
| Q2 24 | $0.48 | $0.88 | ||
| Q1 24 | $0.68 | $1.87 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $180.0M | $359.1M |
| 総負債低いほど良い | $539.5M | $568.7M |
| 株主資本純資産 | $283.7M | $1.1B |
| 総資産 | $1.5B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | 1.90× | 0.52× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $180.0M | $359.1M | ||
| Q3 25 | $158.4M | $382.0M | ||
| Q2 25 | $145.9M | $695.6M | ||
| Q1 25 | $136.0M | $938.5M | ||
| Q4 24 | $161.8M | $912.8M | ||
| Q3 24 | $118.4M | $866.4M | ||
| Q2 24 | $110.4M | $757.0M | ||
| Q1 24 | $120.8M | $718.3M |
| Q4 25 | $539.5M | $568.7M | ||
| Q3 25 | $538.6M | $567.9M | ||
| Q2 25 | $537.8M | $566.8M | ||
| Q1 25 | $537.6M | $566.1M | ||
| Q4 24 | $538.5M | $565.3M | ||
| Q3 24 | $539.5M | $613.0K | ||
| Q2 24 | $540.5M | $563.2M | ||
| Q1 24 | $541.5M | $562.5M |
| Q4 25 | $283.7M | $1.1B | ||
| Q3 25 | $289.5M | $1.1B | ||
| Q2 25 | $290.7M | $1.2B | ||
| Q1 25 | $283.1M | $1.2B | ||
| Q4 24 | $282.6M | $1.1B | ||
| Q3 24 | $288.4M | $1.2B | ||
| Q2 24 | $273.3M | $1.0B | ||
| Q1 24 | $269.3M | $945.5M |
| Q4 25 | $1.5B | $2.2B | ||
| Q3 25 | $1.5B | $2.3B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.4B | $2.1B | ||
| Q4 24 | $1.5B | $2.0B | ||
| Q3 24 | $1.4B | $2.0B | ||
| Q2 24 | $1.4B | $1.9B | ||
| Q1 24 | $1.3B | $1.8B |
| Q4 25 | 1.90× | 0.52× | ||
| Q3 25 | 1.86× | 0.51× | ||
| Q2 25 | 1.85× | 0.49× | ||
| Q1 25 | 1.90× | 0.49× | ||
| Q4 24 | 1.91× | 0.52× | ||
| Q3 24 | 1.87× | 0.00× | ||
| Q2 24 | 1.98× | 0.55× | ||
| Q1 24 | 2.01× | 0.59× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $59.2M | $90.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $55.8M | $81.4M |
| FCFマージンFCF / 売上 | 17.3% | 20.0% |
| 設備投資強度設備投資 / 売上 | 1.1% | 2.2% |
| キャッシュ転換率営業CF / 純利益 | 8.46× | 1.67× |
| 直近12ヶ月FCF直近4四半期 | $141.4M | $354.1M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $59.2M | $90.2M | ||
| Q3 25 | $47.9M | $105.3M | ||
| Q2 25 | $37.3M | $87.1M | ||
| Q1 25 | $11.5M | $107.6M | ||
| Q4 24 | $82.5M | $157.7M | ||
| Q3 24 | $39.5M | $175.1M | ||
| Q2 24 | $43.1M | $84.7M | ||
| Q1 24 | $-29.4M | $127.2M |
| Q4 25 | $55.8M | $81.4M | ||
| Q3 25 | $43.9M | $94.7M | ||
| Q2 25 | $34.6M | $79.1M | ||
| Q1 25 | $7.1M | $98.8M | ||
| Q4 24 | $76.6M | $141.4M | ||
| Q3 24 | $32.0M | $159.3M | ||
| Q2 24 | $38.8M | $73.5M | ||
| Q1 24 | $-34.1M | $119.0M |
| Q4 25 | 17.3% | 20.0% | ||
| Q3 25 | 14.5% | 24.7% | ||
| Q2 25 | 11.6% | 20.9% | ||
| Q1 25 | 2.4% | 26.5% | ||
| Q4 24 | 24.2% | 36.1% | ||
| Q3 24 | 10.8% | 42.0% | ||
| Q2 24 | 13.4% | 18.7% | ||
| Q1 24 | -11.6% | 32.2% |
| Q4 25 | 1.1% | 2.2% | ||
| Q3 25 | 1.3% | 2.8% | ||
| Q2 25 | 0.9% | 2.1% | ||
| Q1 25 | 1.5% | 2.3% | ||
| Q4 24 | 1.9% | 4.2% | ||
| Q3 24 | 2.5% | 4.2% | ||
| Q2 24 | 1.5% | 2.8% | ||
| Q1 24 | 1.6% | 2.2% |
| Q4 25 | 8.46× | 1.67× | ||
| Q3 25 | 2.34× | 3.79× | ||
| Q2 25 | 3.04× | 1.11× | ||
| Q1 25 | 0.71× | 1.47× | ||
| Q4 24 | 2.39× | — | ||
| Q3 24 | 2.07× | 1.34× | ||
| Q2 24 | 3.12× | 1.36× | ||
| Q1 24 | -1.51× | 0.97× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
